Potential risk of mitomycin C at high concentrations on peripheral nerve structure

Tao Sui1, Jinhong Zhang2, Shihao Du1

  • 1Department of Orthopedics, the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China.

Neural Regeneration Research
|September 11, 2014
PubMed

Insights

Local application of mitomycin C (MMC) can prevent epidural adhesion after laminectomy. Studies show low MMC concentrations (0.1-0.5 mg/mL) are safe for peripheral nerves, but higher concentrations may pose risks.

Area of Science:

  • Neurosurgery
  • Pharmacology
  • Biomaterials

Background:

  • Epidural adhesion is a common complication after laminectomy, potentially leading to neurological deficits.
  • Mitomycin C (MMC) is explored for preventing adhesions, but its neurotoxicity at high concentrations is a concern.

Purpose of the Study:

  • To determine the safe concentration range of locally applied mitomycin C (MMC) for preventing epidural adhesion post-laminectomy.
  • To evaluate the impact of varying MMC concentrations on peripheral nerve structure and function in a rat model.

Main Methods:

  • Rats underwent laminectomy at L1.
  • Cotton pads soaked with MMC at concentrations of 0.1, 0.3, 0.5, and 0.7 mg/mL were applied locally for 5 minutes.
  • Sciatic nerve structure and function were assessed.

Main Results:

  • MMC at concentrations of 0.1-0.5 mg/mL showed no adverse effects on sciatic nerve structure or function.
  • A concentration of 0.7 mg/mL significantly reduced sciatic nerve myelin sheath thickness but did not cause functional impairment.
  • Higher concentrations (> 0.7 mg/mL) suggest potential risks to peripheral nerve integrity.

Conclusions:

  • Low concentrations of locally applied mitomycin C (0.1-0.5 mg/mL) appear safe for preventing scar adhesion following laminectomy.
  • Higher concentrations of mitomycin C may present safety risks to peripheral nerve structures, necessitating careful dose selection.